Lumibird Medical Rebrands Its Japanese Subsidiary

Lumibird Medical has announced the rebranding of its Japanese subsidiary. Previously operating under the name Ellex Japan, the company will now be known as Lumibird Medical Japan, effective immediately. This rebranding marks a significant step in aligning the subsidiary’s identity with Lumibird Medical’s global vision and commitment to innovation in ophthalmology.

Growth and Evolution of Lumibird Medical Japan

Founded in Osaka in 2003, the subsidiary has seen remarkable growth over the past two decades. In 2015, the company relocated its headquarters to Tokyo to better serve the Japanese ophthalmology market, further solidifying its presence and reach.

Purpose of the Rebranding

According to a company news release, the rebranding reflects Lumibird Medical’s dedication to advancing patient outcomes and expanding its expertise in ophthalmic diagnosis and treatment.

Leadership Insights

John Hsieh, President & Representative Director of Lumibird Medical Japan, emphasized the growth potential in the region:

“We have seen remarkable growth in the ophthalmic laser market. We are eager to expand further by introducing advanced ophthalmic ultrasound equipment and, as we look to the future, groundbreaking solutions for dry eye treatment. This rebranding represents our dedication to these opportunities for our customers, partners, and stakeholders thanks to the same trusted team and exceptional support.”

Jean-Marc Gendre, CEO of the Lumibird Medical division, shared his enthusiasm for the rebranding:

“We are excited to introduce this new chapter for our Japanese operations. This rebranding underscores our ambition to strengthen our position in the ophthalmology sector in Japan and to bring cutting-edge solutions to our customers more efficiently.”

Upcoming Presence at the Japanese Ophthalmological Society Meeting

Lumibird Medical Japan will officially debut under its new name at the 129th Annual Meeting of the Japanese Ophthalmological Society, taking place in Tokyo from April 17–20, 2025.

Highlights of the Exhibition

       • Showcasing a comprehensive range of ophthalmic laser and ultrasound equipment.

       • Hosting educational seminars focused on glaucoma laser therapy.

Conclusion

The rebranding of Lumibird Medical Japan signals the company’s commitment to growth, innovation, and strengthening its presence in the Japanese ophthalmology market. With advanced technologies and a dedicated team, Lumibird Medical Japan aims to deliver transformative solutions for patients and professionals alike.